Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:08 pm Sale |
2022-12-31 | 13G | Wave Life Sciences Ltd. WVE |
BB Biotech AG | 4,494,458 5.200% |
-108,400 (-2.36%) |
Filing History |
| 2023-02-14 4:07 pm Sale |
2022-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
BB Biotech AG | 9,635,000 6.800% |
-597,973 (-5.84%) |
Filing History |
| 2022-09-29 7:49 pm Purchase |
2022-09-22 | 13G | Revolution Medicines, Inc. RVMD |
BB Biotech AG | 4,602,562 5.200% |
4,602,562 (New Position) |
Filing History |
| 2022-08-30 5:02 pm Sale |
2022-08-11 | 13D | Radius Recycling, Inc. RDUS |
BB Biotech AG | 0 0.000% |
-8,255,714 (Position Closed) |
Filing History |
| 2022-04-14 12:01 pm Purchase |
2022-04-11 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB Biotech AG | 3,988,402 11.000% |
548,402 (+15.94%) |
Filing History |
| 2022-02-11 4:57 pm Purchase |
2021-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB Biotech AG | 3,440,000 9.500% |
1,540,000 (+81.05%) |
Filing History |
| 2022-02-11 4:51 pm Purchase |
2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BB Biotech AG | 4,312,292 7.900% |
153,390 (+3.69%) |
Filing History |
| 2022-02-11 4:49 pm Purchase |
2021-12-31 | 13G | Molecular Templates, Inc. MTEM |
BB Biotech AG | 719,467 19.200% |
83,292 (+13.09%) |
Filing History |
| 2022-02-11 4:48 pm Sale |
2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
BB Biotech AG | 0 0.000% |
-141,125 (Position Closed) |
Filing History |
| 2022-02-11 4:47 pm Purchase |
2021-12-31 | 13G | Myovant Sciences Ltd. MYOV |
BB Biotech AG | 6,122,039 6.600% |
1,365,000 (+28.69%) |
Filing History |
| 2022-02-11 4:46 pm Purchase |
2021-12-31 | 13G | ESSA Pharma Inc. EPIX |
BB Biotech AG | 5,015,814 11.400% |
250,000 (+5.25%) |
Filing History |
| 2022-02-11 4:44 pm Purchase |
2021-12-31 | 13G | Generation Bio Co. GBIO |
BB Biotech AG | 3,853,180 6.800% |
1,460,000 (+61.01%) |
Filing History |
| 2022-02-11 4:42 pm Purchase |
2021-12-31 | 13G | Wave Life Sciences Ltd. WVE |
BB Biotech AG | 4,602,858 7.800% |
2,000,000 (+76.84%) |
Filing History |
| 2022-02-11 4:42 pm Purchase |
2021-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
BB Biotech AG | 10,232,973 7.200% |
2,012,973 (+24.49%) |
Filing History |
| 2022-02-11 4:41 pm Purchase |
2021-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
BB Biotech AG | 491,815 9.200% |
38,500 (+8.49%) |
Filing History |
| 2022-02-11 4:39 pm Purchase |
2021-12-31 | 13G | Scholar Rock Holding Corporation SRRK |
BB Biotech AG | 2,275,125 6.500% |
19,474 (+0.86%) |
Filing History |
| 2022-02-11 4:39 pm Unchanged |
2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BB Biotech AG | 4,477,964 7.100% |
0 (Unchanged) |
Filing History |
| 2022-02-11 4:38 pm Purchase |
2021-12-31 | 13G | MacroGenics, Inc. MGNX |
BB Biotech AG | 7,275,564 11.900% |
1,250,000 (+20.74%) |
Filing History |
| 2022-02-11 4:36 pm Purchase |
2021-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
BB Biotech AG | 3,170,104 5.400% |
210,000 (+7.09%) |
Filing History |
| 2022-02-11 4:34 pm Sale |
2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
BB Biotech AG | 0 0.000% |
-2,680,283 (Position Closed) |
Filing History |